Sirio Pharma (300791) — Net Asset Quality Index
Sirio Pharma (300791) has a Net Asset Quality Index of 46.4% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥5.74 Billion minus total liabilities of CN¥3.07 Billion yields net assets of CN¥2.66 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read Sirio Pharma balance sheet liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Sirio Pharma Net Asset Quality Index Over Time (2016–2024)
This chart shows how Sirio Pharma's Net Asset Quality Index has evolved across 9 annual periods from 2016 to 2024. As of June 2025, the index stands at 46.4%, representing net assets of CN¥2.66 Billion against total assets of CN¥5.74 Billion CNY. For live market cap and overall valuation, see 300791 stock market capitalisation.
Annual Net Asset Quality Index for Sirio Pharma (2016–2024)
The table below presents the year-by-year Net Asset Quality Index for Sirio Pharma from 2016 to 2024, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check 300791 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 48.1% | CN¥2.64 Billion | CN¥5.49 Billion | CN¥2.84 Billion | ▼ -1.2 pp |
| 2023 | 49.4% | CN¥2.57 Billion | CN¥5.20 Billion | CN¥2.63 Billion | ▼ -15.1 pp |
| 2022 | 64.5% | CN¥2.70 Billion | CN¥4.19 Billion | CN¥1.48 Billion | ▼ -2.1 pp |
| 2021 | 66.6% | CN¥2.54 Billion | CN¥3.82 Billion | CN¥1.28 Billion | ▼ -15.8 pp |
| 2020 | 82.4% | CN¥2.18 Billion | CN¥2.65 Billion | CN¥466.95 Million | ▼ -0.1 pp |
| 2019 | 82.5% | CN¥1.95 Billion | CN¥2.36 Billion | CN¥414.01 Million | ▲ +31.7 pp |
| 2018 | 50.8% | CN¥784.05 Million | CN¥1.54 Billion | CN¥759.53 Million | ▲ +5.7 pp |
| 2017 | 45.1% | CN¥580.20 Million | CN¥1.29 Billion | CN¥707.58 Million | ▲ +13.2 pp |
| 2016 | 31.8% | CN¥464.98 Million | CN¥1.46 Billion | CN¥997.00 Million | — |